Skip to main content
. 1998 Apr 18;316(7139):1191–1196. doi: 10.1136/bmj.316.7139.1191

Figure 1.

Figure 1

 Quarterly tracking data for selegiline prescriptions dispensed in United Kingdom before and after publication of results of Parkinson’s Disease Research Group of the United Kingdom.1 Source: Scriptcount (Taylor Nelson AGB)—volume of prescriptions dispensed based on representative sample of 300 pharmacies projected to give total for United Kingdom